Low Birth Weight Fetuses With Caffeine Use
Association of Low Birth Weight Fetuses With Caffeine Use
1 other identifier
observational
500
1 country
1
Brief Summary
Globally, it has been estimated that 15.5% of all infantsare born low birth weight, defined as birthweight less than 2,500 g .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 27, 2018
CompletedFirst Posted
Study publicly available on registry
November 29, 2018
CompletedStudy Start
First participant enrolled
November 30, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2019
CompletedJanuary 9, 2019
January 1, 2019
2 months
November 27, 2018
January 8, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
The number of pregnant ladies who will have low birth weight babies
Mothers who will give birth to low birth weight infants
within 2 months
Study Arms (1)
Pregnant ladies who are caffeine using
ladies who uses caffeine during pregnancy
Interventions
A questionaire will be made to pregnant ladies who take caffeine during pregnancy
Eligibility Criteria
Age group: 18-40 •Pregnant females attending regular post-natal care visits
You may qualify if:
- Age group: 18-40
- Pregnant females attending regular post-natal care visits
You may not qualify if:
- Female patients with other acute or chronic illness
- Cardiovascular disease
- Neoplasms
- Current diabetes mellitus, pregnancy induced diabetes
- Renal impairment (serum creatinine 120 mol/liter), and hypertension (blood pressure 140/85 mm Hg).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aljazeera Hospitallead
- Kasr El Aini Hospitalcollaborator
Study Sites (1)
Algazeerah and Kasralainy hospital
Giza, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Mahmoud Alalfy
Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 27, 2018
First Posted
November 29, 2018
Study Start
November 30, 2018
Primary Completion
February 1, 2019
Study Completion
February 15, 2019
Last Updated
January 9, 2019
Record last verified: 2019-01
Data Sharing
- IPD Sharing
- Will not share